Mei juan Wang

Dr. Mei juan Wang


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2025 in Cancers
Verified
Journal Article
Open access
PDF file
MWMei juan Wang
Mei juan Wang
CGChao Gao
Chao Gao
XHXin Huang
Xin Huang
MWMin Wang
Min Wang
SZShuai Zhang
Shuai Zhang
LLLianyong Li
Lianyong Li
Pancreatic cancer is a highly malignant digestive system tumor characterized by covert onset and rapid progression, with a 5-year survival rate of less than 10%. Most patients have already reached an advanced or metastatic stage at the time of diagnosis. Therefore, it is particularly important to study the occurrence, development, and drug resistance mechanisms of pancreatic cancer. In recent years, the development of 3D tumor cell culture technology has provided new avenues for pancreatic cancer research. Patient-derived organoids (PDOs) are micro-organ structures that are obtained directly from the patient’s body and rapidly expand in vitro. PDOs have the ability to self-renew and self-organize and retain the genetic heterogeneity and molecular characteristics of the original tumor. However, the use of organoids is limited because most patients with pancreatic ductal adenocarcinoma (PDAC) are inoperable. Endoscopic ultrasound-guided fine-needle aspiration/biopsy (EUS-FNA/FNB) is an important method for obtaining tissue samples from non-surgical pancreatic cancer patients. This article reviews the factors that affect the formation of pancreatic cancer organoids using EUS-FNA/FNB. High-quality samples, sterile operations, and optimized culture media are key to successfully generating organoids. Additionally, individual patient differences and disease stages can impact the formation of organoids. Pancreatic cancer organoids constructed using EUS-FNA/FNB have significant potential, suggesting new approaches for research and treatment.

27 October 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
YXYujiao Xu
Yujiao Xu
LZLichao Zhang
Lichao Zhang
MWMei juan Wang
Mei juan Wang
XHXin Huang
Xin Huang
SZShaojie Zheng
Shaojie Zheng
LLLianyong Li
Lianyong Li
Background: Successful generation of patient-derived organoids (PDOs) from pancreatic ductal adenocarcinoma (PDAC) depends on an adequate amount of viable tissue. After routine endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) yields tissue for pathological diagnosis, additional needle passes are typically required to obtain organoid-culture material. This study examined whether air-flush tissue recovery (ATR) of residual needle-tract tissue can derive pancreatic cancer organoids without extra passes. Methods: We enrolled 10 PDAC patients who underwent EUS-FNA at two centers (The Ninth Medical Center of Chinese PLA General Hospital and the Second Hospital of Hebei Medical University) between February and June 2026. Using a self-controlled design, conventional FNA tissue strips (FNA group) and air-flush-recovered needle-tract residuals (ATR group) were collected from each patient and used to establish organoids. The two groups were compared for P3-generation passage rate, histological features, and molecular characteristics. Results: The ≥P3 success rate was 60.0% (6/10) in both the FNA and ATR groups. The overall organoid establishment rate (at least one method) was 80.0% (8/10). Hematoxylin and eosin (HE) staining and immunohistochemistry showed that organoids from both sources retained the histological morphology and key molecular features of the primary tumor, with consistent expression patterns. Conclusions: Harvesting residual tissue from the EUS-FNA needle tract by air flushing enables successful establishment of pancreatic cancer PDOs. The establishment success rate is comparable to that of organoids derived from conventional FNA specimens. In high-risk patients who cannot tolerate additional passes, a single ATR sample can still provide material for organoid generation; simultaneously culturing FNA tissue strips together with ATR residuals improved the overall organoid establishment rate from one puncture. This minimally invasive protocol is straightforward to perform and merits validation in larger cohorts.